20Sep
Investor Science Call from ECTRIMS
Friday, September 20, 2024 from 16:00 CEST / 10:00am EDT / 07:00 am PDT
16:00 CEST
Investor Presentation
7Dec
R&D Day
Sanofi was pleased to host investors and analysts for its R&D Day held in person at the Kimpton Hotel Eventi in New York City on Thursday, December 7, 2023.
08:30 EST
Investor Presentation
29Jun
Vaccines Investor Event
Sanofi was pleased to host investors and analysts for its Vaccines Investor Event held in person on June 29th, 2023
15:00 - 18:00
Investor Presentation
22May
ATS Investor Call
Sanofi was pleased to invite investors and analysts to participate in its ATS Investor Call on Monday, May 22, 2023.
(18h00 – 19h30 CEST / 12:00pm – 1:30pm EDT)
18:00 - 19:30
Investor Presentation
13Jul
Hemophilia Investor Event
Sanofi was pleased to host investors and analysts for its Hemophilia Investor Event held in person at ExCel London on Wednesday, July 13, 2022. (2:00pm GMT / 15h00 CET / 9:00am EST)
15:00 - 17:00
Investor Presentation
5Jul
ESG Investor Event
Sanofi was pleased to invite investors and analysts to participate in its ESG Investor Event held in-person at the Sanofi Headquarters (54, rue La Boétie, 75008 Paris) on Tuesday, July 5, 2022. (14:00h CET / 8:00am EST)
14:00 - 16:00
Investor Presentation
18May
1Apr
29Mar
Immunology Investor Event
Sanofi was pleased to host investors and analysts for its Immunology Investor Event held in person in our new Sanofi Cambridge Headquarters in Cambridge, Massachusetts. (16h00 CET / 10:00am EST)
16:00 - 18:00
Investor Presentation
25Feb
ACTRIMS Investor Call
Sanofi was pleased to invite investors and analysts to participate in a live webcast discussing tolebrutinib data presented during the ACTRIMS scientific program (February 24-26, 2022). (16h00 CET / 10:00am EST)
16:00 - 18:00
Investor Presentation